Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
           Standard; Transfer of Listing.

On February 13, 2023, Kismet Acquisition Two Corp., a Cayman Islands exempted company (the "Company"), received a deficiency notice from the Nasdaq Stock Market ("Nasdaq") notifying the Company that, as a result of the resignation of Verdi Israelyan from the board of directors of the Company (the "Board") and the audit committee of the Board ("Audit Committee") on September 5, 2022, the Company is no longer in compliance with the continued listing requirements set forth in Nasdaq Listing Rule 5605 regarding the composition of the Audit Committee, because the Audit Committee is now comprised of only two members instead of the required three members.

The notice from Nasdaq further provided that, consistent with Nasdaq Listing Rules 5605(c)(4), Nasdaq will provide the Company with a cure period in order to regain compliance with such rule as follows: (i) until the earlier to occur of the Company's next annual shareholders' meeting or September 5, 2023; or (ii) if the next annual shareholders' meeting is held before March 6, 2023, then the Company must evidence compliance no later than March 6, 2023.

The Company expects to regain compliance with Nasdaq Listing Rule 5605 prior to the expiration of the cure period provided by Nasdaq.


                                       1

© Edgar Online, source Glimpses